
    
      Patients will take metformin twice a day for 3 weeks before surgery. The hypothesis is that
      metformin will reduce cell proliferation rates (Ki67) and increase apoptoses (TUNEL)in tumor
      tissue.

      The study will collect and analyze pre- and post-treatment blood specimens for:

        -  Serum glucose

        -  Insulin levels

        -  Estradiol

        -  HOMA test

        -  Glycosylated haemoglobin
    
  